
Arthroplasty
Perioperative corticosteroids vs. placebo for serum PF1.2, PAP and IL-6 after THA
J Arthroplasty. 2016 Jun;31(6):1208-12.40 patients undergoing total hip arthroplasty were randomized to undergo the procedure with or without perioperative administration of corticosteroids (oral prednisone and intravenous hydrocortisone). The purpose of this study was to determine if perioperative corticosteroid resulted in significantly different serum concentrations of prothrombin fragment 1.2 (PF1.2), plasmin-alpha-2-antiplasmin (PAP) and, interkeukin-6 (IL-6). Additionally, differences in pain, analgesic consumption, and patient function performance were evaluated during initial hospital stay and at 3-months post-surgery. Results demonstrated comparable serum concentrations of PF1.2 and PAP at all follow-up points. Significantly reduced concentrations of IL-6 at 6 and 24 hours, maximum pain scores on postoperative day 0, and total patient-controlled analgesia volume was observed in the corticosteroid group. All other comparisons, including those evaluated at 3 months, were comparable between groups.
Unlock the full article
Get unlimited access to OrthoEvidence with a free trial
Start TrialCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or continue reading this full article
Register Now

Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.